A Comprehensive Review of the Genetic Etiology and Management of Orofacial Clefts

Abstract

Cleft lip (CL) and cleft palate (CP), collectively referred to as orofacial clefts (OFCs), are among the most common birth defects and can have significant effects on speech, nutrition, and physical and psychosocial development. Manifestation, classification, and treatment plans of OFCs are diverse and not standardized. Recent technological advancements and genetic testing have enabled researchers to propose relationships between certain genes and the development of OFCs. Potential genetic precursors for OFCs have been found to be numerous and diverse. Treatment strategies are also numerous and vary greatly between individuals. In this review article, we summarize the most commonly discussed genetic factors in the literature, variation in classification, and advances in management.

Keywords

cleft lip / cleft palate / orofacial clefts

References

[1] K. Garland, Growth and Development Analysis of Unilateral Cleft Palate Patients at One, Five, and Ten Years. PhD Thesis (University of Western Ontario, 2020).

[2] N. B. Semer and M. Adler-Lavan, Practical Plastic Surgery for Nonsurgeons (Hanley & Belfus, 2001).

[3] N. Salari, N. Darvishi, M. Heydari, S. Bokaee, F. Darvishi, and M. Mohammadi, “Global Prevalence of Cleft Palate, Cleft Lip and Cleft Palate and Lip: A Comprehensive Systematic Review and Meta-Analysis,” Journal of Stomatology, Oral and Maxillofacial Surgery 123, no. 2 (2022): 110–120.

[4] R. S. Kantar, U. S. Hamdan, J. N. Muller, et al., “Global Prevalence and Burden of Orofacial Clefts: A Systematic Analysis for the Global Burden of Disease Study 2019,” Journal of Craniofacial Surgery 34, no. 7 (2023): 2012–2015.

[5] S. G. Sankar, Texboook of Orthodontics, 1st ed. (Paras Medical, 2011).

[6] I. C. Taritsa, J. K. Ledwon, A. Bajaj, and A. K. Gosain, “12-Year Trends of Orofacial Clefts in the United States: Highlighting Racial/Ethnic Differences in Prevalence of Cleft Lip and Cleft Palate,” Cleft Palate Craniofacial Journal 62, no. 5 (2025): 820–828.

[7] P. A. Mossey, J. Little, R. G. Munger, M. J. Dixon, and W. C. Shaw, “Cleft Lip and Palate,” Lancet 374, no. 9703 (2009): 1773–1785.

[8] K. Christensen, “The 20th Century Danish Facial Cleft Population: Epidemiological and Genetic-Epidemiological Studies,” Cleft Palate-Craniofacial Journal 36, no. 2 (1999): 96–104.

[9] R. H. Belcher, S. A. Patel, M. Kynes, et al., “Demographics and Trends of Cleft Lip and Palate Patients Born in Tennessee From 2000 to 2017,” International Journal of Pediatric Otorhinolaryngology 163 (2022): 111312.

[10] E. B. Stallings, J. L. Isenburg, R. E. Rutkowski, et al., “National Population-Based Estimates for Major Birth Defects, 2016–2020,” Birth Defects Research 116, no. 1 (2024): e2301.

[11] M. J. Dixon, M. L. Marazita, T. H. Beaty, and J. C. Murray, “Cleft Lip and Palate: Understanding Genetic and Environmental Influences,” Nature Reviews Genetics 12, no. 3 (2011): 167–178.

[12] M. Yow, A. Jin, and G. S. H. Yeo, “Epidemiologic Trends of Infants With Orofacial Clefts in a Multiethnic Country: A Retrospective Population-Based Study,” Scientific Reports 11, no. 1 (2021): 7556.

[13] K. Philipp, Q. Anja, S. Boris, et al., “Epidemiological and Clinical Evaluation of Patients With a Cleft in Lower Saxony Germany: A Mono-Center Analysis,” Clinical Oral Investigations 27, no. 9 (2023): 5661–5670.

[14] S. M. W. Pool, L. M. van der Lek, K. de Jong, C. Vermeij-Keers, and C. M. Mouës-Vink, “Embryologically Based Classification Specifies Gender Differences in the Prevalence of Orofacial Cleft Subphenotypes,” Cleft Palate-Craniofacial Journal 58, no. 1 (2021): 54–60.

[15] P. Mossey, “Epidemiology Underpinning Research in the Aetiology of Orofacial Clefts,” Orthodontics & Craniofacial Research 10, no. 3 (2007): 114–120.

[16] C. S. Chung, M. P. Mi, A. M. Beechert, and I. B. Borecki, “Genetic Epidemiology of Cleft Lip With or Without Cleft Palate in the Population of Hawaii,” Genetic Epidemiology 4, no. 6 (1987): 415–423.

[17] D. F. Wyszynski and T. Wu, “Prenatal and Perinatal Factors Associated With Isolated Oral Clefting,” Cleft Palate-Craniofacial Journal 39, no. 3 (2002): 370–375.

[18] L. Allen, J. Williams, N. Townsend, et al., “Socioeconomic Status and Non-Communicable Disease Behavioural Risk Factors in Low-Income and Lower-Middle-Income Countries: A Systematic Review,” Lancet Global Health 5, no. 3 (2017): e277–e289.

[19] P. M. Som and T. P. Naidich, “Illustrated Review of the Embryology and Development of the Facial Region, Part 2: Late Development of the Fetal Face and Changes in the Face From the Newborn to Adulthood,” American Journal of Neuroradiology 35, no. 1 (2014): 10–18.

[20] N. Bernheim, M. Georges, C. Malevez, A. De Mey, and A. Mansbach, “Embryology and Epidemiology of Cleft Lip and Palate,” supplement, B-ENT 2, no. S4 (2006): S11–S19, PMID: 17366840.

[21] W. Proffit, H. Fields, and D. Sarver, “Complex Nonskeletal Problems in Preadolescent Children: Preventive and Interceptive Treatment,” in Contemporary Orthodontics. 5th ed. (Elsevier/Mosby, 2012), 463–470.

[22] A. Nakajima, C. F Shuler, A. O. D. Gulka, and J.-I. Hanai, “TGF-β Signaling and the Epithelial-Mesenchymal Transition During Palatal Fusion,” International Journal of Molecular Sciences 19, no. 11 (2018): 3638.

[23] J.-I. Iwata, A. Suzuki, T. Yokota, et al., “TGFΒ Regulates Epithelial-Mesenchymal Interactions Through WNT Signaling Activity to Control Muscle Development in the Soft Palate,” Development 141, no. 4 (2014): 909–917.

[24] E. Janečková, J. Feng, T. Guo, et al., “Canonical Wnt Signaling Regulates Soft Palate Development by Mediating Ciliary Homeostasis,” Development 150, no. 5 (2023): dev201189.

[25] T. Naicker, A. Alade, C. Adeleke, et al., “Novel IRF6 Variant in Orofacial Cleft Patients From Durban, South Africa,” Molecular Genetics & Genomic Medicine 11, no. 5 (2023): e2138.

[26] J. W. Park, I. McIntosh, J. B. Hetmanski, et al., “Association Between IRF6 and Nonsyndromic Cleft Lip With or Without Cleft Palate in Four Populations,” Genetics in Medicine 9, no. 4 (2007): 219–227.

[27] F. Rahimov, P. Nieminen, P. Kumari, et al., “High Incidence and Geographic Distribution of Cleft Palate in Finland Are Associated With the IRF6 Gene,” Nature Communications 15, no. 1 (2024): 9568.

[28] K. Wattanawong, S. Rattanasiri, M. McEvoy, J. Attia, and A. Thakkinstian, “Association Between IRF6 and 8q24 Polymorphisms and Nonsyndromic Cleft Lip With or Without Cleft Palate: Systematic Review and Meta-Analysis,” Birth Defects Research Part A: Clinical and Molecular Teratology 106, no. 9 (2016): 773–788.

[29] S. Zhang, Q. Chen, C. Yang, et al., “Association Between Variants Around IRF6 and Non-Syndromic Orofacial Cleft in Western Han Chinese,” Oral Diseases 29, no. 3 (2023): 1115–1127.

[30] A. Rojas-Martinez, H. Reutter, O. Chacon-Camacho, et al., “Genetic Risk Factors for Nonsyndromic Cleft Lip With or Without Cleft Palate in a Mesoamerican Population: Evidence for IRF6 and Variants at 8q24 and 10q25,” Birth Defects Research Part A: Clinical and Molecular Teratology 88, no. 7 (2010): 535–537.

[31] J. Salagovic, L. Klimcakova, M. Zabavnikova, et al., “Polymorphisms at 1q32, 8q24, and 17q22 Loci Are Associated With Nonsyndromic Cleft Lip With or Without Cleft Palate Risk in the Slovak Population,” Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 161, no. 2 (2017): 152–157.

[32] L. de Souza, T. Kowalski, J. Ferrari, et al., “Study of IRF6 and 8q24 Region in Non-Syndromic Oral Clefts in the Brazilian Population,” Oral Diseases 22, no. 3 (2016): 241–245.

[33] A. Jugessur, R. T. Lie, A. J. Wilcox, et al., “Cleft Palate, Transforming Growth Factor Alpha Gene Variants, and Maternal Exposures: Assessing Gene-Environment Interactions in Case-Parent Triads,” Genetic Epidemiology 25, no. 4 (2003): 367–374.

[34] B.-M. Kim, Y. H. Kim, D.-H. Kim, J. W. Park, and S.-H. Baek, “Genetic Effect of Transforming Growth Factor Alpha Gene Variants on the Risk of Nonsyndromic Cleft Lip With or Without Palate in Korean Populations,” Cleft Palate-Craniofacial Journal 52, no. 3 (2015): 293–300.

[35] T. C. Carter, A. M. Molloy, F. Pangilinan, et al., “Testing Reported Associations of Genetic Risk Factors for Oral Clefts in a Large Irish Study Population,” Birth Defects Research Part A: Clinical and Molecular Teratology 88, no. 2 (2010): 84–93.

[36] G. Fonseca-Souza, L. Alves-Souza, M. A. H. de Menezes-Oliveira, et al., “Polymorphisms and Dental Age in Non-Syndromic Cleft Lip and Palate: A Cross-Sectional Study,” BMC Pediatrics 25, no. 1 (2025): 80.

[37] C. Stoll, S. Mengsteab, D. Stoll, D. Riediger, A. M. Gressner, and R. Weiskirchen, “Analysis of Polymorphic TGFB1 Codons 10, 25, and 263 in a German Patient Group With Non-Syndromic Cleft Lip, Alveolus, and Palate Compared With Healthy Adults,” BMC Medical Genetics 5, no. 1 (2004): 15.

[38] L. Meng, Z. Bian, R. Torensma, and J. W. Von den Hoff, “Biological Mechanisms in Palatogenesis and Cleft Palate,” Journal of Dental Research 88, no. 1 (2009): 22–33.

[39] E. Ichikawa, A. Watanabe, Y. Nakano, et al., “PAX9 and TGFB3 Are Linked to Susceptibility to Nonsyndromic Cleft Lip With or Without Cleft Palate in the Japanese: Population-Based and Family-Based Candidate Gene Analyses,” Journal of Human Genetics 51, no. 1 (2006): 38–46.

[40] S. K. Rafi, J. P. Goering, A. J. Olm-Shipman, et al., “Anti-Epileptic Drug Topiramate Upregulates TGFβ1 and SOX9 Expression in Primary Embryonic Palatal Mesenchyme Cells: Implications for Teratogenicity,” PLoS One 16, no. 2 (2021): e0246989.

[41] Y.-H. Lee and J.-P. Saint-Jeannet, “Sox9 Function in Craniofacial Development and Disease,” Genesis 49, no. 4 (2011): 200–208.

[42] T. Song, G. Li, G. Jing, et al., “SUMO1 Polymorphisms Are Associated With Non-Syndromic Cleft Lip With or Without Cleft Palate,” Biochemical and Biophysical Research Communications 377, no. 4 (2008): 1265–1268.

[43] M.-R. Tang, Y.-X. Wang, S.-Y. Han, S. Guo, and D. Wang, “SUMO1 Genetic Polymorphisms May Contribute to the Risk of Nonsyndromic Cleft Lip With or Without Palate: A Meta-Analysis,” Genetic Testing and Molecular Biomarkers 18, no. 9 (2014): 616–624.

[44] T. Jagomägi, T. Nikopensius, K. Krjutškov, et al., “MTHFR and MSX1 Contribute to the Risk of Nonsyndromic Cleft Lip/Palate,” European Journal of Oral Sciences 118, no. 3 (2010): 213–220.

[45] N. Y. Kim, Y. H. Kim, J. W. Park, and S.-H. Baek, “Association Between MSX1 SNPS and Nonsyndromic Cleft Lip With or Without Cleft Palate in the Korean Population,” Journal of Korean Medical Science 28, no. 4 (2013): 522–526.

[46] J. Suazo, J. L. Santos, L. Jara, and R. Blanco, “Parent-Of-Origin Effects for MSX1 in a Chilean Population With Nonsyndromic Cleft Lip/Palate,” American Journal of Medical Genetics, Part A 152A, no. 8 (2010): 2011–2016.

[47] J. W. Sull, K.-Y. Liang, J. B. Hetmanski, et al., “Maternal Transmission Effects of the PAX Genes Among Cleft Case–Parent Trios From Four Populations,” European Journal of Human Genetics 17, no. 6 (2009): 831–839.

[48] B. Murdoch, C. DelConte, and M. I. García-Castro, “Pax7 Lineage Contributions to the Mammalian Neural Crest,” PLoS One 7, no. 7 (2012): e41089.

[49] A. C. Böhmer, E. Mangold, P. Tessmann, et al., “Analysis of Susceptibility Loci for Nonsyndromic Orofacial Clefting in a European Trio Sample,” American Journal of Medical Genetics, Part A 161, no. 10 (2013): 2545–2549.

[50] M. I. Khan, P. C. S , M. S. Mustak, and S. Nizamuddin, “Maternal Transmission of the PAX7 Single Nucleotide Polymorphisms Among Indian Cleft Trios,” Global Medical Genetics 10, no. 1 (2023): 006–011.

[51] J. Hao, R. Gao, W. Wu, et al., “Association Between BMP4 Gene Polymorphisms and Cleft Lip With or Without Cleft Palate in a Population From South China,” Archives of Oral Biology 93 (2018): 95–99.

[52] I. Kempa, L. Ambrozaitytė, J. Stavusis, et al., “Association of BMP4 Polymorphisms With Non-Syndromic Cleft Lip With or Without Cleft Palate and Isolated Cleft Palate in Latvian and Lithuanian Populations,” Stomatologija 16, no. 3 (2014): 94–101, PMID: 32211112.

[53] J. Suazo, J. C. Tapia, J. L. Santos, V. G. Castro, A. Colombo, and R. Blanco, “Risk Variants in BMP4 Promoters for Nonsyndromic Cleft Lip/Palate in a Chilean Population,” BMC Medical Genetics 12, no. 1 (2011): 163.

[54] Y. Wang, J. Shi, Q. Zheng, B. Shi, and Z. Jia, “Gene-Gene Interactions Between BMP4 and ARHGAP29 Among Non-Syndromic Cleft Lip Only (NSCLO) Trios From Western Han Chinese Population,” International Journal of Clinical and Experimental Pathology 13, no. 2 (2020): 295–301.

[55] T. A. Manolio, F. S. Collins, N. J. Cox, et al., “Finding the Missing Heritability of Complex Diseases,” Nature 461, no. 7265 (2009): 747–753.

[56] E. J. Leslie, M. A. Taub, H. Liu, et al., “Identification of Functional Variants for Cleft Lip With or Without Cleft Palate in or near PAX7, FGFR2, and NOG by Targeted Sequencing of GWAS Loci,” American Journal of Human Genetics 96, no. 3 (2015): 397–411.

[57] B.-H. Zhang, J.-Y. Shi, Y.-S. Lin, B. Shi, and Z.-L. Jia, “VAX1 Gene Associated Non-Syndromic Cleft Lip With or Without Palate in Western Han Chinese,” Archives of Oral Biology 95 (2018): 40–43.

[58] E. Nasser, E. Mangold, D. C. Tradowsky, et al., “Resequencing of VAX1 in Patients With Nonsyndromic Cleft Lip With or Without Cleft Palate,” Birth Defects Research Part A: Clinical and Molecular Teratology 94, no. 11 (2012): 925–933.

[59] L. Peng, Z. Niu, J. Chen, et al., “Association of Genetic Polymorphisms of VAX1, MAFB, and NTN1 With Nonsyndromic Cleft Lip With or Without Cleft Palate in Chinese Population,” Molecular Genetics and Genomics 297, no. 2 (2022): 553–559.

[60] H. J. Sabbagh, N. P. T. Innes, S. Edris Ahmed, et al., “Molecular Screening of VAX1 Gene Polymorphisms Uncovered the Genetic Heterogeneity of Nonsyndromic Orofacial Cleft Among Saudi Arabian Patients,” Genetic Testing and Molecular Biomarkers 23, no. 1 (2019): 45–50.

[61] Q. Wang, S. Sun, Q. Song, H. Hu, J. An, and J. Liu, “The Risk of Nonsyndromic Cleft Lip With or Without Cleft Palate and Vax1 Rs7078160 Polymorphisms in Southern Han Chinese,” Brazilian Journal of Otorhinolaryngology 87, no. 6 (2021): 718–722.

[62] P. Goyette, A. Pai, R. Milos, et al., “Gene Structure of Human and Mouse Methylenetetrahydrofolate Reductase (MTHFR),” Mammalian Genome 9, no. 8 (1998): 652–656.

[63] A. Amooee, S. A. Dastgheib, S. M. Niktabar, et al., “Association of Fetal MTHFR 677C > T Polymorphism With Non-Syndromic Cleft Lip With or Without Palate Risk: A Systematic Review and Meta-Analysis,” Fetal and Pediatric Pathology 40, no. 4 (2021): 337–353.

[64] P. K. F. de Aguiar, R. D. Coletta, A. M. L. F. de Oliveira, et al., “rs1801133C > T Polymorphism in MTHFR Is a Risk Factor for Nonsyndromic Cleft Lip With or Without Cleft Palate in the Brazilian Population,” Birth Defects Research Part A: Clinical and Molecular Teratology 103, no. 4 (2015): 292–298.

[65] S. M. Niktabar, H. Aarafi, S. A. Dastgheib, et al., “Association of MTHFR 1298A > C Polymorphism With Susceptibility to Non-Syndromic Cleft Lip With or Without Palate: A Case-Control Study and Meta-Analysis,” Fetal and Pediatric Pathology 40, no. 1 (2021): 1–17.

[66] J. Li, D. Feng, S. He, H. Yang, Z. Su, and H. Ye, “Association of MTHFR 677C > T Gene Polymorphism With Neonatal Defects: A Meta-Analysis of 81444 Subjects,” Journal of Obstetrics and Gynaecology 42, no. 6 (2022): 1811–1822.

[67] A. Rafik, L. Rachad, A.-S. Kone, and S. Nadifi, “MTHFR C677T Polymorphism and Risk of Nonsyndromic Cleft Lip With or Without Cleft Palate in the Moroccan Population,” Application of Clinical Genetics 12 (2019): 51–54.

[68] S. Peanchitlertkajorn, M. E. Cooper, Y.-E. Liu, L. L. Field, and M. L. Marazita, “Chromosome 17: Gene Mapping Studies of Cleft Lip With or Without Cleft Palate in Chinese Families,” Cleft Palate-Craniofacial Journal 40, no. 1 (2003): 71–79.

[69] D. Xavier, Y. Arif, R. Murali, et al., “Analysis of Microsatellite Polymorphisms in South Indian Patients With Non Syndromic Cleft Lip and Palate,” Balkan Journal of Medical Genetics 16, no. 1 (2013): 49–54.

[70] R. Jain, R. M. Dharma, M. R. Dinesh, B. C. Amarnath, M. Hegde, and K. M. Pramod, “Association of Wnt9B Rs1530364 and Wnt5A Rs566926 Gene Polymorphisms With Nonsyndromic Cleft Lip and Palate in South Indian Population Using Deoxyribonucleic Acid Sequencing,” Contemporary Clinical Dentistry 11, no. 1 (2020): 60–66.

[71] R. Menezes, A. Letra, A. H. Kim, et al., “Studies With Wnt Genes and Nonsyndromic Cleft Lip and Palate,” Birth Defects Research Part A: Clinical and Molecular Teratology 88, no. 11 (2010): 995–1000.

[72] M. C. Cornelis, A. Agrawal, J. W. Cole, et al., “The Gene, Environment Association Studies Consortium (GENEVA): Maximizing the Knowledge Obtained From GWAS by Collaboration Across Studies of Multiple Conditions,” Genetic Epidemiology 34, no. 4 (2010): 364–372.

[73] J. A. Velázquez-Aragón, M. A. Alcántara-Ortigoza, B. Estandia-Ortega, M. E. Reyna-Fabián, C. D. Méndez-Adame, and A. González-Del Angel, “Gene Interactions Provide Evidence for Signaling Pathways Involved in Cleft Lip/Palate in Humans,” Journal of Dental Research 95, no. 11 (2016): 1257–1264.

[74] C. Fontoura, R. M. Silva, J. M. Granjeiro, and A. Letra, “Further Evidence of Association of the ABCA4 Gene With Cleft Lip/Palate,” European Journal of Oral Sciences 120, no. 6 (2012): 553–557.

[75] T. H. Beaty, J. C. Murray, M. L. Marazita, et al., “A Genome-Wide Association Study of Cleft Lip With and Without Cleft Palate Identifies Risk Variants Near MAFB and ABCA4,” Nature Genetics 42, no. 6 (2010): 525–529.

[76] Y.-H. Wu-Chou, K. P. Chen, Y.-C. Lu, Y.-T. Lin, H.-F. Chang, and L.-J. Lo, “The SNP Rs560426 Within ABCA4-ARHGAP29 Locus and the Risk of Nonsyndromic Oral Clefts,” Cleft Palate Craniofacial Journal 57, no. 6 (2020): 671–677.

[77] A. Zawiślak, K. Woźniak, X. Agirre, et al., “Association of ABCA4 Gene Polymorphisms With Cleft Lip With or Without Cleft Palate in the Polish Population,” International Journal of Environmental Research and Public Health 18, no. 21 (2021): 11483.

[78] M. L. Marazita, A. C. Lidral, J. C. Murray, et al., “Genome Scan, Fine-Mapping, and Candidate Gene Analysis of Non-Syndromic Cleft Lip With or Without Cleft Palate Reveals Phenotype-Specific Differences in Linkage and Association Results,” Human Heredity 68, no. 3 (2009): 151–170.

[79] B. T. Chiquet, R. Henry, A. Burt, et al., “Nonsyndromic Cleft Lip and Palate: CRISPLD Genes and the Folate Gene Pathway Connection,” Birth Defects Research Part A: Clinical and Molecular Teratology 91, no. 1 (2011): 44–49.

[80] R. A. Machado, L. Q. R. de Oliveira, A. L. C. A. Rangel, et al., “Brazilian Multiethnic Association Study of Genetic Variant Interactions Among FOS, CASP8, MMP2 and CRISPLD2 in the Risk of Nonsyndromic Cleft Lip With or Without Cleft Palate,” Dentistry Journal 11, no. 1 (2023): 7.

[81] A. Mijiti, W. Ling, A. Maimaiti, M. Tuerdi, J. Tuerxun, and A. Moming, “Preliminary Evidence of an Interaction Between the CRISPLD2 Gene and Non-Syndromic Cleft Lip With or Without Cleft Palate (NSCL/P) in Xinjiang Uyghur Population, China,” International Journal of Pediatric Otorhinolaryngology 79, no. 2 (2015): 94–100.

[82] P. K. Neela, S. R. Gosla, A. Husain, and V. Mohan, “CRISPLD2 Gene Polymorphisms With Nonsyndromic Cleft Lip Palate in Indian Population,” Global Medical Genetics 7, no. 1 (2020): 22–25.

[83] X. Shen, R.-M. Liu, L. Yang, et al., “The CRISPLD2 Gene Is Involved in Cleft Lip and/Or Cleft Palate in a Chinese Population,” Birth Defects Research Part A: Clinical and Molecular Teratology 91, no. 10 (2011): 918–924.

[84] A. Letra, R. Menezes, M. E. Cooper, et al., “CRISPLD2 Variants Including a C471T Silent Mutation May Contribute to Nonsyndromic Cleft Lip With or Without Cleft Palate,” Cleft Palate-Craniofacial Journal 48, no. 4 (2011): 363–370.

[85] A. N. Mahamad Irfanulla Khan, C. S. Prashanth, and N. Srinath, “Genetic Etiology of Cleft Lip and Cleft Palate,” AIMS Molecular Science 7, no. 4 (2020): 328–348.

[86] A. Ibarra-Arce, M. García-Álvarez, D. Cortés-González, et al., “IRF6 Polymorphisms in Mexican Patients With Non-Syndromic Cleft Lip,” Meta Gene 4 (2015): 8–16.

[87] V. B. Gurramkonda, A. H. Syed, J. Murthy, and B. V. K. S. Lakkakula, “IRF6 Rs2235375 Single Nucleotide Polymorphism Is Associated With Isolated Non-Syndromic Cleft Palate but Not With Cleft Lip With or Without Palate in South Indian Population,” Brazilian Journal of Otorhinolaryngology 84, no. 4 (2018): 473–477.

[88] S. Kondo, B. C. Schutte, R. J. Richardson, et al., “Mutations in IRF6 Cause Van Der Woude and Popliteal Pterygium Syndromes,” Nature Genetics 32, no. 2 (2002): 285–289.

[89] F. Rahimov, M. L. Marazita, A. Visel, et al., “Disruption of an AP-2α Binding Site in an IRF6 Enhancer Is Associated With Cleft Lip,” Nature Genetics 40, no. 11 (2008): 1341–1347.

[90] S. Birnbaum, K. U. Ludwig, H. Reutter, et al., “Key Susceptibility Locus for Nonsyndromic Cleft Lip With or Without Cleft Palate on Chromosome 8q24,” Nature Genetics 41, no. 4 (2009): 473–477.

[91] S. F. A. Grant, K. Wang, H. Zhang, et al., “A Genome-Wide Association Study Identifies a Locus for Nonsyndromic Cleft Lip With or Without Cleft Palate on 8q24,” Journal of Pediatrics 155, no. 6 (2009): 909–913.

[92] S. H. Blanton, A. Burt, S. Stal, J. B. Mulliken, E. Garcia, and J. T. Hecht, “Family-Based Study Shows Heterogeneity of a Susceptibility Locus on Chromosome 8q24 for Nonsyndromic Cleft Lip and Palate,” Birth Defects Research Part A: Clinical and Molecular Teratology 88, no. 4 (2010): 256–259.

[93] T. Nikopensius, L. Ambrozaitytė, K. U. Ludwig, et al., “Replication of Novel Susceptibility Locus for Nonsyndromic Cleft Lip With or Without Cleft Palate on Chromosome 8q24 in Estonian and Lithuanian Patients,” American Journal of Medical Genetics, Part A 149A, no. 11 (2009): 2551–2553.

[94] L. E. Mitchell, “Transforming Growth Factor α Locus and Nonsyndromic Cleft Lip With or Without Cleft Palate: A Reappraisal,” Genetic Epidemiology 14, no. 3 (1997): 231–240.

[95] X.-C. Lu, W. Yu, Y. Tao, et al., “Contribution of Transforming Growth Factor α Polymorphisms to Nonsyndromic Orofacial Clefts: A HuGE Review and Meta-Analysis,” American Journal of Epidemiology 179, no. 3 (2014): 267–281.

[96] G. M. Shaw, C. R. Wasserman, E. J. Lammer, et al., “Orofacial Clefts, Parental Cigarette Smoking, and Transforming Growth Factor-Alpha Gene Variants,” American Journal of Human Genetics 58, no. 3 (1996): 551–561, PMID: 8644715.

[97] G. M. Shaw, S. L. Carmichael, C. Laurent, and S. A. Rasmussen, “Maternal Nutrient Intakes and Risk of Orofacial Clefts,” Epidemiology 17, no. 3 (2006): 285–291.

[98] J. S. Zeiger, T. H. Beaty, K.-Y. Liang, and O. Clefts, “Maternal Smoking, and TGFA: A Meta-Analysis of Gene-Environment Interaction,” Cleft Palate-Craniofacial Journal 42, no. 1 (2005): 58–63.

[99] L. Meng, Y. Jiang, J. You, et al., “PRMT1-Methylated MSX1 Phase Separates to Control Palate Development,” Nature Communications 16, no. 2025 (2025): 949.

[100] H.-J. Won, J.-W. Kim, H.-S. Won, and J.-O. Shin, “Gene Regulatory Networks and Signaling Pathways in Palatogenesis and Cleft Palate: A Comprehensive Review,” Cells 12, no. 15 (2023): 1954.

[101] M. H. van den Boogaard, M. Dorland, F. A. Beemer, and H. K. P. van Amstel, “MSX1 Mutation Is Associated With Orofacial Clefting and Tooth Agenesis in Humans,” Nature Genetics 24, no. 4 (2000): 342–343.

[102] P. Jezewski, A. R. Vieira, C. Nishimura et al., “Complete Sequencing Demonstrates a Role for MSX1 in Nonsyndromic Cleft Lip and Palate,” Journal of Medical Genetics 40, no. 6 (2003): 399–407.

[103] I. Salahshourifar, A. S. Halim, W. A. Wan Sulaiman, and B. A. Zilfalil, “Contribution of MSX1 Variants to the Risk of Non-Syndromic Cleft Lip and Palate in a Malay Population,” Journal of Human Genetics 56, no. 11 (2011): 755–758.

[104] L. Otero, S. Gutiérrez, M. Cháves, C. Vargas, and L. Bérmudez, “Association of MSX1 With Nonsyndromic Cleft Lip and Palate in a Colombian Population,” Cleft Palate-Craniofacial Journal 44, no. 6 (2007): 653–656.

[105] P. Tasanarong, N. Pabalan, P. Tharabenjasin, and H. Jarjanazi, “MSX1 Gene Polymorphisms and Non-Syndromic Cleft Lip With or Without Palate (NSCL/P): A Meta-Analysis,” Oral Diseases 25, no. 6 (2019): 1492–1501.

[106] D. Graf, Z. Malik, S. Hayano, and Y. Mishina, “Common Mechanisms in Development and Disease: BMP Signaling in Craniofacial Development,” Cytokine & Growth Factor Reviews 27 (2016): 129–139.

[107] J. H. Bennett, P. Hunt, and P. Thorogood, “Bone Morphogenetic Protein-2 And-4 Expression During Murine Orofacial Development,” Archives of Oral Biology 40, no. 9 (1995): 847–854.

[108] L. Santos Antunes, E. C. Küchler, P. N. Tannure, et al., “BMP4 Polymorphism Is Associated With Nonsyndromic Oral Cleft in a Brazilian Population,” Cleft Palate-Craniofacial Journal 50, no. 6 (2013): 633–638.

[109] S. Suzuki, M. L. Marazita, M. E. Cooper, et al., “Mutations in BMP4 Are Associated With Subepithelial, Microform, and Overt Cleft Lip,” American Journal of Human Genetics 84, no. 3 (2009): 406–411.

[110] Y.-H. Li, J. Yang, J.-L. Zhang, J.-Q. Liu, Z. Zheng, and D.-H. Hu, “BMP4 Rs17563 Polymorphism and Nonsyndromic Cleft Lip With or Without Cleft Palate: A Meta-Analysis,” Medicine 96, no. 31 (2017): e7676.

[111] R. Assis Machado, I. P. de Toledo, H. Martelli-Júnior, S. R. Reis, E. Neves Silva Guerra, and R. D. Coletta, “Potential Genetic Markers for Nonsyndromic Oral Clefts in the Brazilian Population: A Systematic Review and Meta-Analysis,” Birth Defects Research 110, no. 10 (2018): 827–839.

[112] Z. Zhang, Y. Song, X. Zhao, X. Zhang, C. Fermin, and Y. Chen, “Rescue of Cleft Palate in Msx1-Deficient Mice by Transgenic Bmp4 Reveals a Network of BMP and Shh Signaling in the Regulation of Mammalian Palatogenesis,” Development 129, no. 17 (2002): 4135–4146.

[113] E. Pauws and P. Stanier, “Sumoylation in Craniofacial Disorders,” in SUMO Regulation of Cellular Processes (Springer International Publishing, 2017), 323–335.

[114] C. Chevrier, C. Perret, M. Bahuau, et al., “Fetal and Maternal MTHFR C677T Genotype, Maternal Folate Intake and the Risk of Nonsyndromic Oral Clefts,” American Journal of Medical Genetics, Part A 143A, no. 3 (2007): 248–257.

[115] D. A. Gaspar, S. R. Matioli, R. de Cássia Pavanello, et al., “Maternal MTHFR Interacts With the Offspring’s BCL3 Genotypes, but Not With TGFA, in Increasing Risk to Nonsyndromic Cleft Lip With or Without Cleft Palate,” European Journal of Human Genetics 12, no. 7 (2004): 521–526.

[116] V. Rai, “Strong Association of C677T Polymorphism of Methylenetetrahydrofolate Reductase Gene With Nosyndromic Cleft Lip/Palate (NSCL/P),” Indian Journal of Clinical Biochemistry 33, no. 1 (2018): 5–15.

[117] L. V. K. S. Bhaskar, J. Murthy, and G. Venkatesh Babu, “Polymorphisms in Genes Involved in Folate Metabolism and Orofacial Clefts,” Archives of Oral Biology 56, no. 8 (2011): 723–737.

[118] L. Liu, H. Bu, Y. Yang, et al., “A Targeted, Next-Generation Genetic Sequencing Study on Tetralogy of Fallot, Combined With Cleft Lip and Palate,” Journal of Craniofacial Surgery 28, no. 4 (2017): e351–e355.

[119] M. A. Honein, S. A. Rasmussen, J. Reefhuis, et al., “Maternal Smoking and Environmental Tobacco Smoke Exposure and the Risk of Orofacial Clefts,” Epidemiology 18, no. 2 (2007): 226–233.

[120] J. Little, A. Cardy, M. T. Arslan, et al., “Smoking and Orofacial Clefts: A United Kingdom–Based Case-Control Study,” Cleft Palate Craniofacial Journal 41, no. 4 (2004): 381–386.

[121] S. E. Watkins, R. E. Meyer, R. P. Strauss, and A. S. Aylsworth, “Classification, Epidemiology, and Genetics of Orofacial Clefts,” Clinics in Plastic Surgery 41, no. 2 (2014): 149–163.

[122] S. J. Hwang, T. H. Beaty, S. R. Panny, et al., “Association Study of Transforming Growth Factor Alpha (TGF Alpha) TaqI Polymorphism and Oral Clefts: Indication of Gene-Environment Interaction in a Population-Based Sample of Infants With Birth Defects,” American Journal of Epidemiology 141, no. 7 (1995): 629–636.

[123] A. Ebadifar, R. Hamedi, H. R. KhorramKhorshid, K. Kamali, and F. A. Moghadam, “Parental Cigarette Smoking, Transforming Growth Factor-Alpha Gene Variant and the Risk of Orofacial Cleft in Iranian Infants,” Iranian Journal of Basic Medical Sciences 19, no. 4 (2016): 366–373, PMID: 272799979.

[124] B. L. Eppley, J. A. van Aalst, A. Robey, R. J. Havlik, and A. M. Sadove, “The Spectrum of Orofacial Clefting,” Plastic and Reconstructive Surgery 115, no. 7 (2005): 101e–114e.

[125] T. Wu, H. Schwender, I. Ruczinski, et al., “Evidence of Gene-Environment Interaction for Two Genes on Chromosome 4 and Environmental Tobacco Smoke in Controlling the Risk of Nonsyndromic Cleft Palate,” PLoS One 9, no. 2 (2014): e88088.

[126] T. H. Beaty, I. Ruczinski, J. C. Murray, et al., “Evidence for Gene-Environment Interaction in a Genome Wide Study of Nonsyndromic Cleft Palate,” Genetic Epidemiology 35, no. 6 (2011): 469–478.

[127] T. H. Beaty, J. B. Hetmanski, J. S. Zeiger, et al., “Testing Candidate Genes for Non-Syndromic Oral Clefts Using a Case-Parent Trio Design,” Genetic Epidemiology 22, no. 1 (2002): 1–11.

[128] R. G. Munger, P. A. Romitti, S. Daack-Hirsch, T. L. Burns, J. C. Murray, and J. Hanson, “Maternal Alcohol Use and Risk of Orofacial Cleft Birth Defects,” Teratology 54, no. 1 (1996): 27–33.

[129] L. A. DeRoo, A. J. Wilcox, C. A. Drevon, and R. T. Lie, “First-Trimester Maternal Alcohol Consumption and the Risk of Infant Oral Clefts in Norway: A Population-Based Case-Control Study,” American Journal of Epidemiology 168, no. 6 (2008): 638–646.

[130] J. C. Bell, C. Raynes-Greenow, R. M. Turner, C. Bower, N. Nassar, and C. M. O’Leary, “Maternal Alcohol Consumption During Pregnancy and the Risk of Orofacial Clefts in Infants: A Systematic Review and Meta-Analysis,” Paediatric and Perinatal Epidemiology 28, no. 4 (2014): 322–332.

[131] X. Yin, J. Li, Y. Li, and S. Zou, “Maternal Alcohol Consumption and Oral Clefts: A Meta-Analysis,” British Journal of Oral and Maxillofacial Surgery 57, no. 9 (2019): 839–846.

[132] M. Zhao, Y. Ren, L. Shen, Y. Zhang, and B. Zhou, “Association Between MTHFR C677T and A1298C Polymorphisms and NSCL/P Risk in Asians: A Meta-Analysis,” PLoS One 9, no. 3 (2014): e88242.

[133] S. Chaudhary, “Cleft Lip and Palate - A Review Article,” International Journal of Research and Review 9, no. 7 (2022): 236–243.

[134] A. Sousa, S. Devare, and J. Ghanshani, “Psychological Issues in Cleft Lip and Cleft Palate,” Journal of Indian Association of Pediatric Surgeons 14, no. 2 (2009): 55.

[135] S. Hernández-Díaz, M. M. Werler, A. M. Walker, and A. A. Mitchell, “Folic Acid Antagonists During Pregnancy and the Risk of Birth Defects,” New England Journal of Medicine 343, no. 22 (2000): 1608–1614.

[136] L. B. Holmes, D. F. Wyszynski, and E. Lieberman, “The AED (Antiepileptic Drug) Pregnancy Registry: A 6-Year Experience,” Archives of Neurology 61, no. 5 (2004): 673–678.

[137] S. L. Carmichael and G. M. Shaw, “Maternal Corticosteroid Use and Risk of Selected Congenital Anomalies,” American Journal of Medical Genetics 86, no. 3 (1999): 242–244.

[138] E. J. Lammer, D. T. Chen, R. M. Hoar, et al., “Retinoic Acid Embryopathy,” New England Journal of Medicine 313, no. 14 (1985): 837–841.

[139] I. G. E. Gebuijs, J. R. Metz, J. Zethof, C. E. L. Carels, F. A. D. T. G. Wagener, and J. W. Von den Hoff, “The Anti-Epileptic Drug Valproic Acid Causes Malformations in the Developing Craniofacial Skeleton of Zebrafish Larvae,” Mechanisms of Development 163 (2020): 103632.

[140] G.-A. Jung, J.-Y. Yoon, B.-S. Moon, et al., “Valproic Acid Induces Differentiation and Inhibition of Proliferation in Neural Progenitor Cells via the Beta-Catenin-Ras-ERK-p21Cip/WAF1 Pathway,” BMC Cell Biology 9, no. 1 (2008): 66.

[141] A. Jackson, R. Bromley, J. Morrow, B. Irwin, and J. Clayton-Smith, “In Utero Exposure to Valproate Increases the Risk of Isolated Cleft Palate,” Archives of Disease in Childhood - Fetal and Neonatal Edition 101, no. 3 (2016): F207–F211.

[142] A. V. Margulis, A. A. Mitchell, S. M. Gilboa, et al., “Use of Topiramate in Pregnancy and Risk of Oral Clefts,” American Journal of Obstetrics and Gynecology 207, no. 5 (2012): 405.e1–405.e7.

[143] A. MacFarlane and T. Greenhalgh, “Sodium Valproate in Pregnancy: What Are the Risks and Should We Use a Shared Decision-Making Approach?,” BMC Pregnancy and Childbirth 18, no. 1 (2018): 200.

[144] A. Correa, S. M. Gilboa, L. M. Besser, et al., “Diabetes Mellitus and Birth Defects,” American Journal of Obstetrics and Gynecology 199, no. 3 (2008): 237.e1–237.e9.

[145] A. Åberg, L. Westbom, and B. Källén, “Congenital Malformations Among Infants Whose Mothers Had Gestational Diabetes or Preexisting Diabetes,” Early Human Development 61, no. 2 (2001): 85–95.

[146] M. Cedergren and B. Källén, “Maternal Obesity and the Risk for Orofacial Clefts in the Offspring,” Cleft Palate-Craniofacial Journal 42, no. 4 (2005): 367–371.

[147] M. Stott-Miller, C. L. Heike, M. Kratz, and J. R. Starr, “Increased Risk of Orofacial Clefts Associated With Maternal Obesity: Case-Control Study and Monte Carlo-Based Bias Analysis,” Paediatric and Perinatal Epidemiology 24, no. 5 (2010): 502–512.

[148] M. Laspro, H. T. Brydges, A. N. Verzella, et al., “Association of Commonly Prescribed Antepartum Medications and Incidence of Orofacial Clefting,” Cleft Palate Craniofacial Journal 62, no. 7 (2025): 1164–1174.

[149] L. R. Dolovich, A. Addis, J. M. Vaillancourt, J. D. Power, G. Koren, and T. R. Einarson, “Benzodiazepine Use in Pregnancy and Major Malformations or Oral Cleft: Meta-Analysis of Cohort and Case-Control Studies,” BMJ 317, no. 7162 (1998): 839–843.

[150] B. Rezaallah, D. J. Lewis, H.-F. Zeilhofer, and B.-I. Berg, “Risk of Cleft Lip and/Or Palate Associated With Antiepileptic Drugs: Postmarketing Safety Signal Detection and Evaluation of Information Presented to Prescribers and Patients,” Therapeutic Innovation & Regulatory Science 53, no. 1 (2019): 110–119.

[151] B. N. Wikner, C.-O. Stiller, U. Bergman, C. Asker, and B. Källén, “Use of Benzodiazepines and Benzodiazepine Receptor Agonists During Pregnancy: Neonatal Outcome and Congenital Malformations,” Pharmacoepidemiology and Drug Safety 16, no. 11 (2007): 1203–1210.

[152] M. C. Jones, “Prenatal Diagnosis of Cleft Lip and Palate: Detection Rates, Accuracy of Ultrasonography, Associated Anomalies, and Strategies for Counseling,” Cleft Palate-Craniofacial Journal 39, no. 2 (2002): 169–173.

[153] M. I. Evans, R. F. Hume Jr., M. P. Johnson, et al., “Integration of Genetics and Ultrasonography in Prenatal Diagnosis: Just Looking Is Not Enough,” American Journal of Obstetrics and Gynecology 174, no. 6 (1996): 1925–1931: discussion 1931–1933.

[154] L. M. Wang, K. Y. Leung, and M. Tang, “Prenatal Evaluation of Facial Clefts by Three-Dimensional Extended Imaging,” Prenatal Diagnosis 27, no. 8 (2007): 722–729.

[155] A. S. Smith, J. A. Estroff, C. E. Barnewolt, J. B. Mulliken, and D. Levine, “Prenatal Diagnosis of Cleft Lip and Cleft Palate Using MRI,” American Journal of Roentgenology 183, no. 1 (2004): 229–235.

[156] T. Kosowski, W. Weathers, E. Wolfswinkel, and E. Ridgway, “Cleft Palate,” Seminars in Plastic Surgery 26, no. 4 (2013): 164–169.

[157] J. E. Janis, ed. Essentials of Plastic, 2nd ed. (CRC Press, 2014).

[158] R. Houkes, J. Smit, P. Mossey, et al., “Classification Systems of Cleft Lip, Alveolus and Palate: Results of an International Survey,” Cleft Palate Craniofacial Journal 60, no. 2 (2023): 189–196.

[159] V. Veau, Division Palatine: Anatomie, Chirurgie, Phonétique (Masson et Cie, 1931).

[160] D. A. Kernahan and R. B. Stark, “A New Classification for Cleft Lip and Cleft Palate,” Plastic and Reconstructive Surgery 22, no. 5 (1958): 435–441.

[161] O. Karataş, B. Gözel, and Y. Oztan, “A Modification of the Kernahan “Y” Classification in Cleft Lip and Palate Deformities,” Plastic and Reconstructive Surgery 104, no. 6 (1999): 1933.

[162] M. Khan, H. Ullah, S. Naz, et al., “A Revised Classification of the Cleft Lip and Palate,” Canadian Journal of Plastic Surgery 21, no. 1 (2013): 48–50.

[163] F.-L. Chang, C.-H. Chen, H.-L. Cheng, et al., “Efficacy of Ventilation Tube Insertion With Palatal Repair for Otitis Media in Cleft Palate: Meta-Analysis and Trial Sequential Analysis,” Journal of Personalized Medicine 12, no. 2 (2022): 255.

[164] M. A. Aycart and E. J. Caterson, “Advances in Cleft Lip and Palate Surgery,” Medicina 59, no. 11 (2023): 1932.

[165] M. Abd El-Ghafour, M. A. Aboulhassan, A. R. El-Beialy, et al., “Does Presurgical Taping Change Nose and Lip Aesthetics in Infants With Unilateral Cleft Lip and Palate? A Randomized Controlled Trial,” Plastic and Reconstructive Surgery 150, no. 6 (2022): 1300e–1313e.

[166] R. Pool and T. K. Farnworth, “Preoperative Lip Taping in the Cleft Lip,” Annals of Plastic Surgery 32, no. 3 (1994): 234–249.

[167] D. M. Fisher, “Unilateral Cleft Lip Repair: An Anatomical Subunit Approximation Technique,” Plastic and Reconstructive Surgery 116, no. 1 (2005): 61–71.

[168] M. Deshmukh, S. Vaidya, G. Deshpande, J. Galinde, and S. Natarajan, “Comparative Evaluation of Esthetic Outcomes in Unilateral Cleft Lip Repair Between the Mohler and Fisher Repair Techniques: A Prospective, Randomized, Observer-Blind Study,” Journal of Oral and Maxillofacial Surgery 77, no. 1 (2019): 182.e1–182.e8.

[169] P. A. Mittermiller, S. Martin, D. N. Johns, D. Perrault, E. M. Jablonka, and R. K. Khosla, “Improvements in Cleft Lip Aesthetics With the Fisher Repair Compared to the Mohler Repair,” Plastic and Reconstructive Surgery – Global Open 8, no. 6 (2020): e2919, https://pubmed.ncbi.nlm.nih.gov/32766066/.

[170] T. A. Patel and K. G. Patel, “Comparison of the Fisher Anatomical Subunit and Modified Millard Rotation-Advancement Cleft Lip Repairs,” Plastic and Reconstructive Surgery 144, no. 2 (2019): 238e–245e.

[171] C.-S. Chang, C. G. Wallace, Y.-C. Hsiao, C.-J. Chang, and P. K. Chen, “Botulinum Toxin to Improve Results in Cleft Lip Repair,” Plastic and Reconstructive Surgery 134, no. 3 (2014): 511–516.

[172] I. Apon, C. R. Rogers-Vizena, M. J. Koudstaal, et al., “Barriers and Facilitators to the International Implementation of Standardized Outcome Measures in Clinical Cleft Practice,” Cleft Palate-Craniofacial Journal 59, no. 1 (2022): 5–13.

[173] E. Tsangaris, K. W. Y. Wong Riff, T. Goodacre, et al., “Establishing Content Validity of the CLEFT-Q: A New Patient-Reported Outcome Instrument for Cleft Lip/Palate,” Plastic and Reconstructive Surgery - Global Open 5, no. 4 (2017): e1305.

[174] H. R. Wilhelmsen and R. H. Musgrave, “Complications of Cleft Palate Surgery,” Cleft Palate Journal 3, no. 3 (1966): 223–231.

[175] A.-M. Leow and L.-J. Lo, “Palatoplasty: Evolution and Controversies,” Chang Gung Medical Journal 31, no. 4 (2008): 335–345.

[176] J. Bardach, H. L. Morris, and W. H. Olin, “Late Results of Primary Veloplasty: The Marburg Project,” Plastic and Reconstructive Surgery 73, no. 2 (1984): 207–218.

[177] B. Shi and J. E. Losee, “The Impact of Cleft Lip and Palate Repair on Maxillofacial Growth,” International Journal of Oral Science 7, no. 1 (2015): 14–17.

[178] J. S. Crowley, T. L. Friesen, R. A. Gabriel, et al., “Speech and Audiology Outcomes After Single-Stage Versus Early 2-Stage Cleft Palate Repair,” Annals of Plastic Surgery 86, no. 5S (2021): S360–S366.

[179] P. Naidu, C. A. Yao, D. K. Chong, and W. P. Magee, “Cleft Palate Repair: A History of Techniques and Variations,” Plastic and Reconstructive Surgery - Global Open 10, no. 3 (2022): e4019.

[180] F. Qamar, M. M. McLaughlin, M. Lee, A. J. Pringle, J. Halsey, and S. A. Rottgers, “An Algorithmic Approach for Deploying Buccal Fat Pad Flaps and Buccal Myomucosal Flaps Strategically in Primary and Secondary Palatoplasty,” Cleft Palate-Craniofacial Journal 60, no. 7 (2023): 865–874.

[181] S. S. Kelly, C. A. Suarez, N. A. Mirsky, et al., “Application of 3D Printing in Cleft Lip and Palate Repair,” Journal of Craniofacial Surgery 36, no. 3 (2025): 1071–1079.

[182] D. Luo, B. Chen, and Y. Chen, “Stem Cells-Loaded 3D-Printed Scaffolds for the Reconstruction of Alveolar Cleft,” Frontiers in Bioengineering and Biotechnology 10 (2022): 939199.

[183] J. C. Lee, G. C. Slack, R. Walker, et al., “Maxillary Hypoplasia in the Cleft Patient: Contribution of Orthodontic Dental Space Closure to Orthognathic Surgery,” Plastic and Reconstructive Surgery 133, no. 2 (2014): 355–361.

[184] S. Nirmala, “Dental Concerns of Children With Lip Cleft and Palate - A Review,” Journal of Pediatrics & Neonatal Care 8, no. 4 (2018): 172–178.

[185] E. J. Volpicelli, M. J. Pfaff, K. Hakimi, J. P. Bradley, R. C. Solem, and J. C. Lee, “Age-Related Differences in Psychosocial Function of Children With Craniofacial Anomalies,” Plastic and Reconstructive Surgery 140, no. 4 (2017): 776–784.

[186] N. Yu, J. Yang, Y. Mishina, and W. V. Giannobile, “Genome Editing: A New Horizon for Oral and Craniofacial Research,” Journal of Dental Research 98, no. 1 (2019): 36–45.

[187] K. X. Huang, M. K. Oberoi, R. M. Caprini, et al., “COVID-19 Pandemic Associated With Increased Self-Reported Depressive Symptoms in Patients With Congenital Craniofacial Diagnoses,” Cleft Palate-Craniofacial Journal 60, no. 8 (2023): 949–955.

[188] T. Jo, J. Kim, J. Choi, J. Kim, and W. Jeong, “Unbiased Transcriptome Analysis of Human Cleft Palate Reveals Evolutionally Conserved Molecular Signatures of Development: Experimental Study,” International Journal of Surgery 110, no. 11 (2024): 6933–6940.

[189] F. R. Virani, E. C. Chua, M. R. Timbang, T.-Y. Hsieh, and C. W. Senders, “Three-Dimensional Printing in Cleft Care: A Systematic Review,” Cleft Palate-Craniofacial Journal 59, no. 4 (2022): 484–496.

Rights & permissions

2026 The Author(s). Pediatric Discovery published by John Wiley & Sons Australia, Ltd on behalf of Children's Hospital of Chongqing Medical University.